| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |